CANSINO BIOLOGICS INC (CASBF)
Clinical trial NCT06389513 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2026-05-01 3. primary completion date: 2025-12-01 → 2026-04-10
Clinical trial NCT06389513 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2026-05-01 3. primary completion date: 2025-12-01 → 2026-04-10
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical